Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIAP.L Regulatory News (IAP)

  • There is currently no data for IAP

Statement regarding transaction - Tullett Prebon

7 Jun 2016 07:05

RNS Number : 4024A
ICAP PLC
07 June 2016
 

 

 

 

ICAP plc - Statement regarding transaction with Tullett Prebon

London, 7 June 2016 - ICAP plc (IAP.L), a leading markets operator and provider of post trade risk and information services, notes the statement today from the Competition and Markets Authority ("CMA") announcing that the proposed Transaction to dispose of ICAP's global hybrid voice broking and information business to Tullett Prebon plc is being referred for a phase 2 investigation solely as a result of potential concerns in respect of the voice/hybrid broking ‎of oil products unless suitable remedies are offered.

ICAP is confident that clearance from the CMA will be obtained and, together with Tullett Prebon, is in the process of obtaining the necessary remaining regulatory and competition approvals from relevant authorities. The proposed Transaction remains on track to complete later this year.

Upon completion the ICAP Group will begin to trade as NEX Group plc, a focused electronic and post trade group with a leading portfolio of financial market infrastructure businesses and products.

Ends

Contacts:

Serra Balls

Group Head of Communications

+44 (0) 20 7050 7103

Alex Dee

Head of Investor Relations

+44 (0) 20 7050 7123

Neil Bennett/ Rebecca Mitchell

Maitland

+44 (0) 20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGLGDLDGGBGLR
Date   Source Headline
20th May 20106:00 pmRNSTransaction in Own Shares
19th May 20106:00 pmRNSDirector/PDMR Shareholding
19th May 20107:00 amRNSFinal Results
4th May 20105:01 pmRNSTotal Voting Rights
1st Apr 20101:34 pmRNSDirectorate Change
1st Apr 20101:09 pmRNSTotal Voting Rights
25th Mar 20105:00 pmRNSDirector/PDMR Shareholding
24th Mar 20107:00 amRNSTrading Statement
22nd Mar 20107:00 amRNSStatement re review of cash equities businesses
18th Mar 201010:01 amRNSHolding(s) in Company
18th Mar 20109:46 amRNSUpdate re acquisition of TriOptima
1st Mar 201011:19 amRNSTotal Voting Rights
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20109:30 amRNSBlocklisting Interim Review
15th Feb 20107:00 amRNSStatement re. Press Comment
9th Feb 201012:30 pmRNSDirector/PDMR Shareholding
8th Feb 20105:14 pmRNSHolding(s) in Company
5th Feb 20107:00 amRNSInterim Management Statement
1st Feb 201011:22 amRNSTotal Voting Rights
1st Feb 201010:04 amRNSScrip Dividend Scheme
27th Jan 20105:51 pmRNSDirector/PDMR Shareholding
13th Jan 20106:16 pmRNSScrip Dividend Scheme
11th Jan 20104:43 pmRNSDirector/PDMR Shareholding
4th Jan 20103:28 pmRNSTotal Voting Rights
18th Dec 20095:42 pmRNSStatement Re Settlement with SEC
7th Dec 200912:00 pmRNSHolding(s) in Company
1st Dec 20094:38 pmRNSTotal Voting Rights
23rd Nov 200910:58 amRNSDirectorate Change
20th Nov 20094:44 pmRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim results
2nd Nov 200912:30 pmRNSTotal Voting Rights
23rd Oct 20094:46 pmRNSFormal notice
15th Oct 200910:30 amRNSHolding(s) in Company
6th Oct 200912:00 pmRNSHolding(s) in Company
2nd Oct 200910:00 amRNSHolding(s) in Company
1st Oct 20099:00 amRNSTotal Voting Rights
1st Oct 20097:00 amRNSTrading Statement
28th Sep 20091:20 pmRNSHolding(s) in Company
21st Sep 20092:08 pmRNSDirector/PDMR Shareholding
21st Sep 20092:05 pmRNSDirector/PDMR Shareholding
18th Sep 20095:23 pmRNSHolding(s) in Company
18th Sep 200910:17 amRNSDirectorate Change
11th Sep 20095:02 pmRNSHolding(s) in Company
1st Sep 200911:45 amRNSTotal Voting Rights
21st Aug 20097:00 amRNSBlocklisting
20th Aug 20097:00 amRNSAdditional Listing
14th Aug 20093:10 pmRNSBlocklisting Interim Review
14th Aug 20093:10 pmRNSBlocklisting Interim Review
14th Aug 20093:10 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.